Miriam Koopman

Full Professor

Strategic program(s):

Contact

mkoopma6@umcutrecht.nl

Pure profile

Research groups

Medical oncology colorectal cancer group

Research aim

To improve outcomes and quality of life for all patients with colorectal and anal cancer by developing and validating biomarkers, enhancing therapeutic strategies, refining patient selection, and studying real life treatment outcomes.

Go to group

Recent publications

All publications

Adenocarcinoma of the small intestine cohort Pascale J M Schafrat, Tim R De Back, Felice N Van Erning, Frederieke H Van der Baan, Geraldine R Vink, Miriam Koopman, Ruben S A Goedegebuure, Louis Vermeulen, Ignace H J T De Hingh, Dirkje W Sommeijer,
Acta oncologica (Stockholm, Sweden), 2026, vol. 65, p.363-369

Health-related quality of life and functional outcomes of colon cancer patients in the Netherlands A. J. Pennings, G. R. Vink, S. van Kuijk, M. Koopman, J. Melenhorst, G. L. Beets, A. M. May, S. O. Breukink
Colorectal Disease, 2026, vol. 28

Learning from every patient Maarten J Kamphuis, Irene C van der Schaaf, Roxanne Gal, Joanne M van der Velden, J P Maarten Burbach, Nicolien Kasperts, Jochem R N van der Voort van Zyp, Joost J C Verhoeff, Danny A Young-Afat, Martijn P W Intven, Sofie A M Gernaat, Frederieke H van der Baan, Geraldine R Vink, Miriam Koopman, Faye J Raaijmakers, Fia Cialdella, Tariq A Lalmahomed, Jasmijn M Westerhoff, Renée Hovenier, Eline H Huele, Frederik R Teunissen, Dieuwke R Mink van der Molen, Sophie R de Mol van Otterloo, Merle Hattink, Mathijs L Tomassen, Lois A Daamen, Helena M Verkooijen
Journal of Clinical Epidemiology, 2026, vol. 195

Tumor burden in metastatic colorectal cancer quantified using deep learning models Dania Al-Toma, Ruby Kemna, Mahsoem Ali, Koen Zwart, Michiel J. Zeeuw, Bertine L. Stehouwer, Pim A. de Jong, Sophie Kurk, Manon N.G.J.A. Braat, Jan J.W. Lagendijk, Anne M. May, Miriam Koopman, Inez M. Verpalen, Rutger Jan Swijnenburg, Cornelis J.A. Punt, Geert Kazemier, Guus M. Bol
European Journal of Cancer, 2026, vol. 238

Assessing Overall Survival Benefits in Advanced Cancers Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, Kimmo Porkka, Robin Doeswijk, Peter Mol, Donna R. Rivera, Catherine C. Lerro, Ulrich Peter Rohr, Patrice Verpillat, Antonios Valachis, Dario Trapani, Massimo Di Maio, Nicola Latino, Raul Cordoba, Nathan Cherny, Miriam Koopman, Diogo Martins-Branco, George Pentheroudakis, Douwe Postmus
Clinical Pharmacology and Therapeutics, 2026, vol. 119, p.1080-1087

Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients Avin Ghedri, Frederieke H van der Baan, Johannes M M B Otten, Marloes A G Elferink, Frederiek Terheggen, Mathijs P Hendriks, Anne M May, Miriam Koopman, Cornelis J A Punt, Johannes J M Kwakman,
European Journal of Cancer, 2026, vol. 237

External positions

Member of the Quality Committee - lid - NVMO

Board member - lid - Onconext

Member of the data science and cohorts boards - lid - UMC Utrecht

Vice-chair/secretary of the Dutch Colorectal Cancer Group - vicevoorzitter/secretaris - DCCG

Chair of newly established RWD and digital health working group - voorzitter - ESMO

Faculty member for the Gastro-Intestinal Tumours-colorectal - lid - ESMO

Chair of expertise group colorectal Cancer 'uitkomstgerichte zorg' - voorzitter - FMS

Chair of workpackage 'well defined patient cohorts' of the national growth fund grant application - voorzitter - Oncode accelerator

Leading member of the Health sciences group - lid - NWO-GWI

Expert member of committee 'regie op registers dure geneesmiddelen' - lid - Zorginstituut NL

CRC expert on platform for answering online CRC questions - expert op basis van vraag/antwoord - Kanker.nl

Participant in the international collaboration of ARCAD - Participant, integrating patient-level data - ARCAD

founder and PI of the Dutch Prospective CRC cohort study - founder and PI - PLCRC